Literature DB >> 20093486

Loss of protein kinase C delta gene expression in human squamous cell carcinomas: a laser capture microdissection study.

Vipin Yadav1, Nicole C Yanez, Sarah E Fenton, Mitchell F Denning.   

Abstract

Protein kinase C delta (PKC-delta) protein levels are frequently low in chemically and UV-induced mouse skin tumors as well as in human cutaneous squamous cell carcinomas (SCCs). Furthermore, overexpression of PKC-delta in human SCC lines and mouse epidermis is sufficient to induce apoptosis and suppress tumorigenicity, making PKC-delta a potential tumor suppressor gene for SCCs. Here we report that PKC-delta is lost in human SCCs at the transcriptional level. We used laser capture microdissection to isolate cells from three normal human epidermis and 14 human SCCs with low PKC-delta protein. Analysis by quantitative reverse transcription-PCR revealed that PKC-delta RNA was reduced an average of 90% in the SCCs tested, consistent with PKC-delta down-regulation at the protein level. Analysis of DNA from nine of the same tumors revealed that PKC-delta gene was deleted in only one tumor. In addition, Ras-transformed human keratinocytes, which have selective down-regulation of PKC-delta at both protein and mRNA levels, had significantly repressed human PKC-delta promoter activity. Together, these results indicate that PKC-delta gene expression is suppressed in human SCCs, probably via transcription repression. Our results have implications for the development of topical therapeutic strategies to trigger the re-expression of pro-apoptotic PKC-delta to induce apoptosis in SCCs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20093486      PMCID: PMC2832131          DOI: 10.2353/ajpath.2010.090816

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  32 in total

Review 1.  Proteins of the ETS family with transcriptional repressor activity.

Authors:  G Mavrothalassitis; J Ghysdael
Journal:  Oncogene       Date:  2000-12-18       Impact factor: 9.867

Review 2.  Cutaneous malignancies and their management.

Authors:  J K Padgett; J D Hendrix
Journal:  Otolaryngol Clin North Am       Date:  2001-06       Impact factor: 3.346

3.  Regulation of human involucrin promoter activity by novel protein kinase C isoforms.

Authors:  T Efimova; R L Eckert
Journal:  J Biol Chem       Date:  2000-01-21       Impact factor: 5.157

4.  Laser-capture microdissection.

Authors:  Virginia Espina; Julia D Wulfkuhle; Valerie S Calvert; Amy VanMeter; Weidong Zhou; George Coukos; David H Geho; Emanuel F Petricoin; Lance A Liotta
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

5.  Activation of the nuclear transcription factor SP-1 by insulin rapidly increases the expression of protein kinase C delta in skeletal muscle.

Authors:  Miriam Horovitz-Fried; Avraham I Jacob; Denise R Cooper; Sanford R Sampson
Journal:  Cell Signal       Date:  2006-08-23       Impact factor: 4.315

6.  Patterns of protein kinase C isoenzyme expression in transitional cell carcinoma of bladder. Relation to degree of malignancy.

Authors:  L Langzam; R Koren; R Gal; V Kugel; A Paz; A Farkas; S R Sampson
Journal:  Am J Clin Pathol       Date:  2001-09       Impact factor: 2.493

7.  Transgenic mice overexpressing protein kinase Cdelta in the epidermis are resistant to skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate.

Authors:  P J Reddig; N E Dreckschmidt; H Ahrens; R Simsiman; C P Tseng; J Zou; T D Oberley; A K Verma
Journal:  Cancer Res       Date:  1999-11-15       Impact factor: 12.701

8.  The protein kinase C delta catalytic fragment targets Mcl-1 for degradation to trigger apoptosis.

Authors:  Leonid A Sitailo; Shalini S Tibudan; Mitchell F Denning
Journal:  J Biol Chem       Date:  2006-08-10       Impact factor: 5.157

9.  Analysis of protein kinase C delta (PKC delta) expression in endometrial tumors.

Authors:  Elaine M Reno; James M Haughian; Irina K Dimitrova; Twila A Jackson; Kenneth R Shroyer; Andrew P Bradford
Journal:  Hum Pathol       Date:  2007-10-24       Impact factor: 3.466

10.  p63 and p73, members of the p53 gene family, transactivate PKCdelta.

Authors:  Raffaella Ponassi; Alessandro Terrinoni; Anissa Chikh; Alessandro Rufini; Anna Maria Lena; Berna S Sayan; Gerry Melino; Eleonora Candi
Journal:  Biochem Pharmacol       Date:  2006-09-07       Impact factor: 5.858

View more
  10 in total

1.  The many hats of protein kinase Cδ: one enzyme with many functions.

Authors:  Nir Qvit; Daria Mochly-Rosen
Journal:  Biochem Soc Trans       Date:  2014-12       Impact factor: 5.407

2.  Congenital anomalies and rhabdoid tumor associated with 22q11 germline deletion and somatic inactivation of the SMARCB1 tumor suppressor.

Authors:  George Toth; Claudia B Zraly; Tricia L Thomson; Carolyn Jones; Shawn Lapetino; Jonathan Muraskas; Jiwang Zhang; Andrew K Dingwall
Journal:  Genes Chromosomes Cancer       Date:  2011-03-15       Impact factor: 5.006

Review 3.  Protein kinase C and cancer: what we know and what we do not.

Authors:  R Garg; L G Benedetti; M B Abera; H Wang; M Abba; M G Kazanietz
Journal:  Oncogene       Date:  2013-12-16       Impact factor: 9.867

Review 4.  From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma.

Authors:  Vladimir Ratushny; Michael D Gober; Ryan Hick; Todd W Ridky; John T Seykora
Journal:  J Clin Invest       Date:  2012-02-01       Impact factor: 14.808

5.  Protein arginine methyltransferase 5 (PRMT5) signaling suppresses protein kinase Cδ- and p38δ-dependent signaling and keratinocyte differentiation.

Authors:  Santosh R Kanade; Richard L Eckert
Journal:  J Biol Chem       Date:  2011-12-23       Impact factor: 5.157

6.  Repeated Treatments with Ingenol Mebutate Prevents Progression of UV-Induced Photodamage in Hairless Mice.

Authors:  Andrés Már Erlendsson; Daniel Thaysen-Petersen; Christiane Bay; Andreas Hald; Kresten Skak; John Robert Zibert; Uwe Paasch; Hans Christian Wulf; Merete Haedersdal
Journal:  PLoS One       Date:  2016-09-16       Impact factor: 3.240

7.  Protein kinase C: an attractive target for cancer therapy.

Authors:  Barbara Marengo; Chiara De Ciucis; Roberta Ricciarelli; Maria A Pronzato; Umberto M Marinari; Cinzia Domenicotti
Journal:  Cancers (Basel)       Date:  2011-02-01       Impact factor: 6.639

8.  Role of FGFR2b expression and signaling in keratinocyte differentiation: sequential involvement of PKCδ and PKCα.

Authors:  Benedetta Rosato; Danilo Ranieri; Monica Nanni; Maria Rosaria Torrisi; Francesca Belleudi
Journal:  Cell Death Dis       Date:  2018-05-01       Impact factor: 8.469

9.  Genome wide DNA methylation profiling identifies specific epigenetic features in high-risk cutaneous squamous cell carcinoma.

Authors:  David Hervás-Marín; Faatiemah Higgins; Onofre Sanmartín; Jose Antonio López-Guerrero; M Carmen Bañó; J Carlos Igual; Inma Quilis; Juan Sandoval
Journal:  PLoS One       Date:  2019-12-20       Impact factor: 3.240

Review 10.  Multiple subcellular localizations and functions of protein kinase Cδ in liver cancer.

Authors:  Kohji Yamada; Kiyotsugu Yoshida
Journal:  World J Gastroenterol       Date:  2022-01-14       Impact factor: 5.742

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.